FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2988335955> ?p ?o ?g. }

• W2988335955 endingPage "1292" @default.
• W2988335955 startingPage "1284" @default.
• W2988335955 abstract "The efficacy of pre-procedural beta-blocker use in patients with acute coronary syndrome (ACS) is not well established in the current percutaneous coronary intervention (PCI) era. We investigate the effect of pre-procedural beta-blocker use on clinical outcomes in patients with ACS undergoing PCI. Among 44,967 consecutive cases of PCI enrolled in the nationwide, retrospective, multicenter registry (K-PCI registry), 31,040 patients with ACS were selected and analyzed. We classified patients into pre-procedural beta-blocker group (n = 8,678) and pre-procedural no-beta-blocker group (n = 22,362) according to the use of beta-blockers at least for two weeks before index PCI. Propensity score-matching analysis was performed and resulted in 7,445 pairs. The primary outcome was in-hospital cardiac death. In propensity score-matched populations, the pre-procedural beta-blocker group had a lower incidence of in-hospital cardiac death compared with the pre-procedural no-beta-blocker group (1.1% versus 2.0%, unadjusted odds ratio [OR]: 0.56, 95% confidence interval [CI]: 0.42-0.73, P < 0.01). In subgroup analysis, the pre-procedural beta-blocker group had a lower incidence of in-hospital cardiac death, compared with the pre-procedural no-beta-blocker group in ST-segment elevation myocardial infarction subpopulation (3.1% versus 6.1%, unadjusted OR: 0.49, 95% CI: 0.34-0.71, P < 0.01) and non-ST-segment elevation myocardial infarction subpopulation (1.5% versus 2.9%, unadjusted OR: 0.51, 95% CI: 0.33-0.79, P < 0.01). However, in unstable angina subpopulation, the in-hospital cardiac death rate was comparable between both groups. In conclusion, the use of pre-procedural beta-blocker was associated with a lower risk of in-hospital cardiac death in patients with ACS undergoing PCI. This result adds to the body of evidence that use of pre-procedural beta-blocker in patients with ACS might be reasonable." @default.
• W2988335955 created "2019-11-22" @default.
• W2988335955 creator A5003146557 @default.
• W2988335955 creator A5012152027 @default.
• W2988335955 creator A5017663318 @default.
• W2988335955 creator A5027953921 @default.
• W2988335955 creator A5034392525 @default.
• W2988335955 creator A5034576646 @default.
• W2988335955 creator A5037488366 @default.
• W2988335955 creator A5038699850 @default.
• W2988335955 creator A5039502897 @default.
• W2988335955 creator A5046307071 @default.
• W2988335955 creator A5057520198 @default.
• W2988335955 creator A5057833986 @default.
• W2988335955 creator A5069014578 @default.
• W2988335955 creator A5069167592 @default.
• W2988335955 creator A5089411899 @default.
• W2988335955 date "2019-11-30" @default.
• W2988335955 modified "2023-09-23" @default.
• W2988335955 title "Effect of Pre-Procedural Beta-Blocker on Clinical Outcome after Percutaneous Coronary Intervention in Acute Coronary Syndrome" @default.
• W2988335955 cites W1956440423 @default.
• W2988335955 cites W1966953116 @default.
• W2988335955 cites W1983107066 @default.
• W2988335955 cites W1990892910 @default.
• W2988335955 cites W2053735438 @default.
• W2988335955 cites W2070568974 @default.
• W2988335955 cites W2071099613 @default.
• W2988335955 cites W2085879694 @default.
• W2988335955 cites W2088864406 @default.
• W2988335955 cites W2114369401 @default.
• W2988335955 cites W2123165866 @default.
• W2988335955 cites W2126125759 @default.
• W2988335955 cites W2139961672 @default.
• W2988335955 cites W2145318712 @default.
• W2988335955 cites W2160414137 @default.
• W2988335955 cites W2167557672 @default.
• W2988335955 cites W2412798966 @default.
• W2988335955 cites W2617274206 @default.
• W2988335955 cites W2620014928 @default.
• W2988335955 cites W2738364056 @default.
• W2988335955 cites W2769525997 @default.
• W2988335955 cites W3184177771 @default.
• W2988335955 cites W4239111797 @default.
• W2988335955 cites W4243502284 @default.
• W2988335955 cites W4298541770 @default.
• W2988335955 cites W52877415 @default.
• W2988335955 doi "https://doi.org/10.1536/ihj.19-175" @default.
• W2988335955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31735782" @default.
• W2988335955 hasPublicationYear "2019" @default.
• W2988335955 type Work @default.
• W2988335955 sameAs 2988335955 @default.
• W2988335955 citedByCount "1" @default.
• W2988335955 countsByYear W29883359552021 @default.
• W2988335955 crossrefType "journal-article" @default.
• W2988335955 hasAuthorship W2988335955A5003146557 @default.
• W2988335955 hasAuthorship W2988335955A5012152027 @default.
• W2988335955 hasAuthorship W2988335955A5017663318 @default.
• W2988335955 hasAuthorship W2988335955A5027953921 @default.
• W2988335955 hasAuthorship W2988335955A5034392525 @default.
• W2988335955 hasAuthorship W2988335955A5034576646 @default.
• W2988335955 hasAuthorship W2988335955A5037488366 @default.
• W2988335955 hasAuthorship W2988335955A5038699850 @default.
• W2988335955 hasAuthorship W2988335955A5039502897 @default.
• W2988335955 hasAuthorship W2988335955A5046307071 @default.
• W2988335955 hasAuthorship W2988335955A5057520198 @default.
• W2988335955 hasAuthorship W2988335955A5057833986 @default.
• W2988335955 hasAuthorship W2988335955A5069014578 @default.
• W2988335955 hasAuthorship W2988335955A5069167592 @default.
• W2988335955 hasAuthorship W2988335955A5089411899 @default.
• W2988335955 hasBestOaLocation W29883359551 @default.
• W2988335955 hasConcept C126322002 @default.
• W2988335955 hasConcept C156957248 @default.
• W2988335955 hasConcept C164705383 @default.
• W2988335955 hasConcept C167135981 @default.
• W2988335955 hasConcept C17923572 @default.
• W2988335955 hasConcept C2777698277 @default.
• W2988335955 hasConcept C2778198053 @default.
• W2988335955 hasConcept C2778742482 @default.
• W2988335955 hasConcept C2780400711 @default.
• W2988335955 hasConcept C44249647 @default.
• W2988335955 hasConcept C45393284 @default.
• W2988335955 hasConcept C500558357 @default.
• W2988335955 hasConcept C71924100 @default.
• W2988335955 hasConceptScore W2988335955C126322002 @default.
• W2988335955 hasConceptScore W2988335955C156957248 @default.
• W2988335955 hasConceptScore W2988335955C164705383 @default.
• W2988335955 hasConceptScore W2988335955C167135981 @default.
• W2988335955 hasConceptScore W2988335955C17923572 @default.
• W2988335955 hasConceptScore W2988335955C2777698277 @default.
• W2988335955 hasConceptScore W2988335955C2778198053 @default.
• W2988335955 hasConceptScore W2988335955C2778742482 @default.
• W2988335955 hasConceptScore W2988335955C2780400711 @default.
• W2988335955 hasConceptScore W2988335955C44249647 @default.
• W2988335955 hasConceptScore W2988335955C45393284 @default.
• W2988335955 hasConceptScore W2988335955C500558357 @default.
• W2988335955 hasConceptScore W2988335955C71924100 @default.
• W2988335955 hasIssue "6" @default.
• W2988335955 hasLocation W29883359551 @default.

• next